stockrow
Monday 2 November 2026
Export RYAM’s income statement to Excel — free account
Rayonier Advanced Materials Inc.
RYAM Basic Materials Chemicals
Rayonier Advanced Materials Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 10.1% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +91.0%
- Free cash flow
- +69.9%
- Total debt
- +3.90%
Quarter to June 2026, against a year earlier
6.66
0.05
+0.76%
Follow RYAM
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.36 | 0.52 | 0.27 | 0.33 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
106.04 | 23.27 | 12.19 | (27.20) | |
P/B ratio |
2.72 | 3.24 | 1.24 | 1.43 | |
Price to Tangible BV |
2.78 | 3.29 | 1.26 | 1.45 | |
EV/Sales |
0.85 | 1.00 | 0.75 | 0.82 | |
EV/EBITDA |
13.23 | 14.59 | 7.48 | 8.36 | |
EV/Operating CF |
24.28 | 88.63 | 45.88 | 25.77 | |
EV/FCF |
(34.15) | (17.16) | (11.96) | (14.93) | |
Quick Ratio |
0.64 | 0.63 | 0.75 | 0.70 | |
Current Ratio |
1.37 | 1.37 | 1.58 | 1.57 | |
Net Debt/EBITDA |
27.98 | (21.83) | 12.19 | 16.71 | |
Debt/Assets |
47.83% | 45.79% | 44.30% | 44.19% | |
Debt/Equity |
3.98 | 3.33 | 2.46 | 2.35 | |
Asset Turnover |
0.87 | 0.76 | 0.75 | 0.74 | |
Operating CF/Net income |
(0.15) | (0.39) | (1.47) | 3.99 | |
Capex/Depreciation |
(0.79) | (0.66) | (0.36) | (0.71) | |
Interest Coverage |
(0.26) | (2.83) | 0.42 | 0.39 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.58% | 6.01% | 4.53% | 6.70% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.22% | 0.24% | 0.19% | 0.41% | |
Graham Net Nets |
(1.72) | (1.22) | (2.22) | (1.79) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(26.72%) | (63.69%) | (107.30%) | (86.57%) | |
Free Cash Flow Yield |
(6.89%) | (11.28%) | (23.31%) | (16.62%) | |
Revenue per Share |
5.57 | 4.75 | 6.30 | 5.27 | |
Operating CF per Share |
0.07 | 0.48 | 0.48 | (0.27) | |
Capex per Share |
(0.38) | (0.33) | (0.25) | (0.35) | |
Free Cash Flow per Share |
(0.30) | 0.15 | 0.23 | (0.62) | |
Cash per Share |
0.84 | 1.01 | 1.13 | 1.15 | |
Shareholders Equity per Share |
2.88 | 3.42 | 4.74 | 5.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.88 | 3.42 | 4.74 | 5.05 | |
Free Cash Flow |
(20.35) | 9.93 | 15.33 | (41.48) | |
Working Capital |
138.62 | 144.02 | 208.01 | 214.37 | |
Capital Expenditures |
(25.35) | (22.00) | (16.93) | (23.69) | |
Net Current Asset Value |
(914.63) | (908.79) | (873.42) | (867.29) | |
EV/EBIT |
0.00 | 0.00 | 267.69 | 278.18 | |
Capex to Sales |
0.07 | 0.07 | 0.04 | 0.07 | |
Price to Operating Income |
0.00 | 0.00 | 95.99 | 112.11 | |
| Other line items | |||||
Average Receivables |
166.77 | 170.43 | 204.96 | 190.47 | |
Average Payables |
191.73 | 201.15 | 193.35 | 169.53 | |
Average Inventory |
214.59 | 217.88 | 222.99 | 244.02 | |
Average Assets |
1,687.39 | 1,892.46 | 1,944.01 | 1,977.73 | |
Average Common Equity |
268.54 | 458.72 | 515.22 | 535.46 |
Columns are period end dates